Literature DB >> 29912367

Identification of distinct conformations associated with monomers and fibril assemblies of mutant huntingtin.

Jan Ko1, J Mario Isas2, Adam Sabbaugh1, Jung Hyun Yoo1, Nitin K Pandey2, Anjalika Chongtham1, Mark Ladinsky1, Wei-Li Wu1, Heike Rohweder3, Andreas Weiss3, Douglas Macdonald4, Ignacio Munoz-Sanjuan4, Ralf Langen2, Paul H Patterson1, Ali Khoshnan1.   

Abstract

The N-terminal fragments of mutant huntingtin (mHTT) misfold and assemble into oligomers, which ultimately bundle into insoluble fibrils. Conformations unique to various assemblies of mHTT remain unknown. Knowledge on the half-life of various multimeric structures of mHTT is also scarce. Using a panel of four new antibodies named PHP1-4, we have identified new conformations in monomers and assembled structures of mHTT. PHP1 and PHP2 bind to epitopes within the proline-rich domain (PRD), whereas PHP3 and PHP4 interact with motifs formed at the junction of polyglutamine (polyQ) and polyproline (polyP) repeats of HTT. The PHP1- and PHP2-reactive epitopes are exposed in fibrils of mHTT exon1 (mHTTx1) generated from recombinant proteins and mHTT assemblies, which progressively accumulate in the nuclei, cell bodies and neuropils in the brains of HD mouse models. Notably, electron microscopic examination of brain sections of HD mice revealed that PHP1- and PHP2-reactive mHTT assemblies are present in myelin sheath and in vesicle-like structures. Moreover, PHP1 and PHP2 antibodies block seeding and subsequent fibril assembly of mHTTx1 in vitro and in a cell culture model of HD. PHP3 and PHP4 bind to epitopes in full-length and N-terminal fragments of monomeric mHTT and binding diminishes as the mHTTx1 assembles into fibrils. Interestingly, PHP3 and PHP4 also prevent the aggregation of mHTTx1 in vitro highlighting a regulatory function for the polyQ-polyP motifs. These newly detected conformations may affect fibril assembly, stability and intercellular transport of mHTT.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29912367      PMCID: PMC6005051          DOI: 10.1093/hmg/ddy141

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  51 in total

1.  Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.

Authors:  Edward J Wild; Roberto Boggio; Douglas Langbehn; Nicola Robertson; Salman Haider; James R C Miller; Henrik Zetterberg; Blair R Leavitt; Rainer Kuhn; Sarah J Tabrizi; Douglas Macdonald; Andreas Weiss
Journal:  J Clin Invest       Date:  2015-04-06       Impact factor: 14.808

2.  α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.

Authors:  W Peelaerts; L Bousset; A Van der Perren; A Moskalyuk; R Pulizzi; M Giugliano; C Van den Haute; R Melki; V Baekelandt
Journal:  Nature       Date:  2015-06-10       Impact factor: 49.962

3.  Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease.

Authors:  Amber L Southwell; Jan Ko; Paul H Patterson
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

Review 4.  Huntington disease.

Authors:  Gillian P Bates; Ray Dorsey; James F Gusella; Michael R Hayden; Chris Kay; Blair R Leavitt; Martha Nance; Christopher A Ross; Rachael I Scahill; Ronald Wetzel; Edward J Wild; Sarah J Tabrizi
Journal:  Nat Rev Dis Primers       Date:  2015-04-23       Impact factor: 52.329

5.  Identifying polyglutamine protein species in situ that best predict neurodegeneration.

Authors:  Jason Miller; Montserrat Arrasate; Elizabeth Brooks; Clare Peters Libeu; Justin Legleiter; Danny Hatters; Jessica Curtis; Kenneth Cheung; Preethi Krishnan; Siddhartha Mitra; Kartika Widjaja; Benjamin A Shaby; Gregor P Lotz; Yvonne Newhouse; Emily J Mitchell; Alex Osmand; Michelle Gray; Vanitha Thulasiramin; Frédéric Saudou; Mark Segal; X William Yang; Eliezer Masliah; Leslie M Thompson; Paul J Muchowski; Karl H Weisgraber; Steven Finkbeiner
Journal:  Nat Chem Biol       Date:  2011-10-30       Impact factor: 15.040

6.  N17 Modifies mutant Huntingtin nuclear pathogenesis and severity of disease in HD BAC transgenic mice.

Authors:  Xiaofeng Gu; Jeffrey P Cantle; Erin R Greiner; C Y Daniel Lee; Albert M Barth; Fuying Gao; Chang Sin Park; Zhiqiang Zhang; Susana Sandoval-Miller; Richard L Zhang; Marc Diamond; Istvan Mody; Giovanni Coppola; X William Yang
Journal:  Neuron       Date:  2015-02-05       Impact factor: 17.173

7.  Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer.

Authors:  Bankanidhi Sahoo; Irene Arduini; Kenneth W Drombosky; Ravindra Kodali; Laurie H Sanders; J Timothy Greenamyre; Ronald Wetzel
Journal:  PLoS One       Date:  2016-06-06       Impact factor: 3.240

8.  Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core.

Authors:  Hsiang-Kai Lin; Jennifer C Boatz; Inge E Krabbendam; Ravindra Kodali; Zhipeng Hou; Ronald Wetzel; Amalia M Dolga; Michelle A Poirier; Patrick C A van der Wel
Journal:  Nat Commun       Date:  2017-05-24       Impact factor: 14.919

9.  Generation and Characterization of Knock-in Mouse Models Expressing Versions of Huntingtin with Either an N17 or a Combined PolyQ and Proline-Rich Region Deletion.

Authors:  Emily A André; Elise M Braatz; Jeh-Ping Liu; Scott O Zeitlin
Journal:  J Huntingtons Dis       Date:  2017

10.  The Q175 mouse model of Huntington's disease shows gene dosage- and age-related decline in circadian rhythms of activity and sleep.

Authors:  Dawn H Loh; Takashi Kudo; Danny Truong; Yingfei Wu; Christopher S Colwell
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

View more
  10 in total

1.  Structural Model of the Proline-Rich Domain of Huntingtin Exon-1 Fibrils.

Authors:  Alexander S Falk; José M Bravo-Arredondo; Jobin Varkey; Sayuri Pacheco; Ralf Langen; Ansgar B Siemer
Journal:  Biophys J       Date:  2020-10-20       Impact factor: 4.033

2.  Dynamics of the Proline-Rich C-Terminus of Huntingtin Exon-1 Fibrils.

Authors:  Bethany G Caulkins; Silvia A Cervantes; J Mario Isas; Ansgar B Siemer
Journal:  J Phys Chem B       Date:  2018-10-04       Impact factor: 2.991

3.  Amplification of neurotoxic HTTex1 assemblies in human neurons.

Authors:  Anjalika Chongtham; J Mario Isas; Nitin K Pandey; Anoop Rawat; Jung Hyun Yoo; Tara Mastro; Mary B Kennedy; Ralf Langen; Ali Khoshnan
Journal:  Neurobiol Dis       Date:  2021-09-24       Impact factor: 5.996

Review 4.  Striatal Induction and Spread of the Huntington's Disease Protein: A Novel Rhes Route.

Authors:  Srinivasa Subramaniam
Journal:  J Huntingtons Dis       Date:  2022

5.  Gut Bacteria Regulate the Pathogenesis of Huntington's Disease in Drosophila Model.

Authors:  Anjalika Chongtham; Jung Hyun Yoo; Theodore M Chin; Ngozi D Akingbesote; Ainul Huda; J Lawrence Marsh; Ali Khoshnan
Journal:  Front Neurosci       Date:  2022-06-02       Impact factor: 5.152

Review 6.  Hunting for the cause: Evidence for prion-like mechanisms in Huntington's disease.

Authors:  Kirby M Donnelly; Cevannah M Coleman; Madison L Fuller; Victoria L Reed; Dayna Smerina; David S Tomlinson; Margaret M Panning Pearce
Journal:  Front Neurosci       Date:  2022-08-24       Impact factor: 5.152

7.  Huntingtin fibrils with different toxicity, structure, and seeding potential can be interconverted.

Authors:  J Mario Isas; Nitin K Pandey; Hui Xu; Kazuki Teranishi; Alan K Okada; Ellisa K Fultz; Anoop Rawat; Anise Applebaum; Franziska Meier; Jeannie Chen; Ralf Langen; Ansgar B Siemer
Journal:  Nat Commun       Date:  2021-07-13       Impact factor: 14.919

8.  Disease-related Huntingtin seeding activities in cerebrospinal fluids of Huntington's disease patients.

Authors:  C Y Daniel Lee; Nan Wang; Koning Shen; Matthew Stricos; Peter Langfelder; Kristina H Cheon; Etty P Cortés; Harry V Vinters; Jean Paul Vonsattel; Nancy S Wexler; Robert Damoiseaux; Judith Frydman; X William Yang
Journal:  Sci Rep       Date:  2020-11-20       Impact factor: 4.379

9.  Expression of mutant exon 1 huntingtin fragments in human neural stem cells and neurons causes inclusion formation and mitochondrial dysfunction.

Authors:  Rhia Ghosh; Alison Wood-Kaczmar; Lucianne Dobson; Edward J Smith; Eva C Sirinathsinghji; Janos Kriston-Vizi; Iain P Hargreaves; Robert Heaton; Frank Herrmann; Andrey Y Abramov; Amanda J Lam; Simon J Heales; Robin Ketteler; Gillian P Bates; Ralph Andre; Sarah J Tabrizi
Journal:  FASEB J       Date:  2020-04-23       Impact factor: 5.834

10.  Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology.

Authors:  Marie Rieux; Melanie Alpaugh; Giacomo Sciacca; Martine Saint-Pierre; Maria Masnata; Hélèna L Denis; Sébastien A Lévesque; Frank Herrmann; Chantal Bazenet; Alexandre P Garneau; Paul Isenring; Ray Truant; Abid Oueslati; Peter V Gould; Anne Ast; Erich E Wanker; Steve Lacroix; Francesca Cicchetti
Journal:  Mol Psychiatry       Date:  2020-06-08       Impact factor: 15.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.